AN ACT INCREASING THE BOND AUTHORIZATION FOR THE CONNECTICUT BIOSCIENCE INNOVATION FUND.

SB 124 increases the bond authorization for the Connecticut Bioscience Innovation Fund by $25 million, allowing the fund to issue additional bonds to raise capital. This expansion directly supports bioscience companies, research institutions, and innovators in Connecticut by providing more funding for research, development, and commercialization projects. The key mechanism is raising the legal limit on bonds the fund can authorize, without changing its existing purpose or eligibility criteria. The bill focuses solely on increasing available funding capacity for the state's bioscience sector.